Resources

Daily doses of metformin improved the metabolism and increased the lifespans of middle-aged male mice….

In a randomized controlled trial researchers also looked at pregnancy and the risk for GDM-related adverse effects….

Procalcitonin, a 116-amino acid peptide of calcitonin, is a new diagnostic marker of bacterial infections…. 

Christina Kanaka-Gantenbein, MD, PhD Acidosis management  Severe acidosis is reversible by fluid and insulin replacement. Insulin stops lipolysis and further ketone production and allows ketoacids to be metabolized, generating bicarbonate.4 Moreover, treatment of hypovolemia improves tissue perfusion and renal function, thereby increasing the excretion of organic acids. Controlled trials have …

This week, we continue our series of Homerun Slides from Dr. Stanley Schwartz focusing on the obesity epidemic. This week’s topics include: Gene Variants and Binge Eating as Predictors of Co-morbidities and Outcome of Treatment in Severe Obesity, Health Benefits of Modest Weight Loss, and a graphic representation of the …

Joy Pape, RN, BSN, CDE, WOCN, CFCN, FAADE Dr. Ronald Krauss, MD, Senior Scientist and Director of Atherosclerosis Research at Children’s Hospital Oakland Research Institute, Adjunct Professor in the Department of Medicine at UCSF and in the Department of Nutritional Sciences at UC Berkeley, and Guest Senior Scientist in the …

With its large tactile buttons and fully audible features, the GLUCOCARD® Expression™ has quickly become a cost effective alternative for diabetic users with visual and/or hearing impairments. This talking meter, in both English and Spanish, has the most frequently requested features by both users and healthcare providers. Connecting to the ARK …

Intensification of therapy for patients with type 2 diabetes who have suboptimal glucose control is often delayed….

Nonaneurysmal subarachnoid hemorrhage (SAH) appears to be a distinct microvascular complication of type 1 diabetes….

The FDA has acknowledged receipt of a resubmission of the new drug application (NDA) for dapagliflozin, an SGLT-2 inhibitor for the treatment of type 2 diabetes…. Astra Zeneca and Bristol-Myers Squibb (BMS) have announced that the agency has issued a new Prescription Drug User Fee Act goal date of January …